Experiment: 2MI7

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
2	2D 1H-13C HSQC	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
3	3D HNCO	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
4	3D HN(CA)CO	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
5	3D CBCA(CO)NH	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
6	3D HNCACB	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
7	3D H(CC)(CO)NH TOCSY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
8	3D CC(CO)NH TOCSY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
9	3D HCCH-TOCSY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
10	3D (H)CCH3-TOCSY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
11	2D 1H-1H NOESY aromatic	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
12	3D 1H-13C NOESY aromatic	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
13	3D 1H-15N NOESY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
14	4D 1H-15N NOESY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	92% H2O/8% D2O	60	5.6	ambient	303
15	4D 1H-13C NOESY	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
16	2D 1H-13C HSQC	0.95 mM [U-10% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303
17	2D 1H-13C HSQC	0.95 mM [U-100% 13C; U-100% 15N] a3Y, 30 mM [U-100% 2H] sodium acetate, 30 mM sodium chloride, 0.25 mM DSS, 0.02 % (w/v) sodium azide	99.99% D2O	60	5.6	ambient	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	750
2	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
simulated annealing		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	NOE violation cutoff >0.1A, bb dihedral angle violation cutoff >2 degrees, then lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	32
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	Felix		Accelrys Software Inc.
3	chemical shift assignment	Sparky	3.113	Goddard
4	peak picking	Sparky	3.113	Goddard
5	noe integration	Sparky	3.113	Goddard
6	secondary structure analysis	TALOS+		Cornilescu, Delaglio and Bax
7	structure calculation	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read
8	refinement	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read
9	structure evaluation	PSVS	1.5	Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

2MI7 | pdb_00002mi7

Solution NMR structure of alpha3Y

Prepare Data

Validate Data

Deposit Data

Help and Resources

.id_divider{ color: #ccc; padding: 0 10px 0 10px; } .extended_id_info{ color: #ccc; font-size: 18px; position: relative; top: -10px; left: 4px; } 2MI7 | pdb_00002mi7

Solution NMR structure of alpha3Y

2MI7 | pdb_00002mi7